<code id='A3A7455ACE'></code><style id='A3A7455ACE'></style>
    • <acronym id='A3A7455ACE'></acronym>
      <center id='A3A7455ACE'><center id='A3A7455ACE'><tfoot id='A3A7455ACE'></tfoot></center><abbr id='A3A7455ACE'><dir id='A3A7455ACE'><tfoot id='A3A7455ACE'></tfoot><noframes id='A3A7455ACE'>

    • <optgroup id='A3A7455ACE'><strike id='A3A7455ACE'><sup id='A3A7455ACE'></sup></strike><code id='A3A7455ACE'></code></optgroup>
        1. <b id='A3A7455ACE'><label id='A3A7455ACE'><select id='A3A7455ACE'><dt id='A3A7455ACE'><span id='A3A7455ACE'></span></dt></select></label></b><u id='A3A7455ACE'></u>
          <i id='A3A7455ACE'><strike id='A3A7455ACE'><tt id='A3A7455ACE'><pre id='A3A7455ACE'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:hotspot    Page View:84
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Hepatitis C has a cure — but many Americans still lack access to it
          Hepatitis C has a cure — but many Americans still lack access to it

          AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

          read more
          Biden's order seeks to regulate AI risk without stifling innovation
          Biden's order seeks to regulate AI risk without stifling innovation

          AdobePresidentBidenorderedthenation’sleadinghealthagenciesonMondaytodevelopaplanforregulatingartific

          read more
          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more

          Bird flu researchers hone in on Finland’s mink farms

          MinkslookoutfromacageatafurfarminBelarus.SergeiGrits/APHELSINKI—ItwasthequietthatstoodouttoTarjaSiro